Mary Dibiase
Chief Operating Officer · X4 Pharmaceuticals, Inc
IndividualSelling only2 10b5-1 trades
- 2024
- Oct 8, 2024
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mary Dibiase files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Adam R. Craig - $461K in XFOR purchases and sales in the last 12 months
- David Kirske - $143K in XFOR purchases and sales in the last 12 months
- John Volpone - $109K in XFOR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mary Dibiase?
Mary Dibiase is a corporate insider, tracked as Chief Operating Officer of X4 Pharmaceuticals, Inc (XFOR). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Mary Dibiase last file a Form 4?
The only primary Form 4 on record is dated 8 October 2024.
Has Mary Dibiase been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($38K) across all tracked filings.
